From your initial consultation to medication delivery, everything is handled seamlessly onlineallowing you to achieve your health goals without the hassle
Understanding the compounded tirzepatide starting dose that is right for your situation is part of this consultation
What is the recommended starting dose of tirzepatide for weight loss
Phase 3 trial results (REDEFINE program) showed CagriSema produced approximately 22-25% body weight reduction, putting it in direct competition with tirzepatide and retatrutide
Focus on a balanced, nutrient-dense diet emphasizing lean proteins, vegetables, fruits, whole grains, and healthy fats
Add-on to 1-3 oral anti-hyperglycemic agents (metformin, sulfonylurea, or SGLT-2 inhibitor) SURPASS-4 (NCT03730662) was a 104-week open-label trial (52-week primary endpoint) that randomized 2002 adult patients with type 2 diabetes mellitus with increased cardiovascular risk to subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or insulin glargine 100 units/mL once daily (1:1:1:3 ratio) on a background of metformin (95%) and/or sulfonylureas (54%) and/or SGLT2 inhibitors (25%)
